Evidence for the efficacy of peginterferon alfa-2a (40 KD) (PEGASYS) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors
- 30 April 2002
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: